Literature DB >> 25181956

Effect of tonsillectomy and its timing on renal outcomes in Caucasian IgA nephropathy patients.

Tibor Kovács1, Tibor Vas, Csaba P Kövesdy, Péter Degrell, Györgyi Nagy, Zsuzsanna Rékási, István Wittmann, Judit Nagy.   

Abstract

PURPOSE: The role of tonsillectomy in the treatment of IgA nephropathy in Caucasian patients is controversial.
METHODS: A retrospective cohort study was conducted in 264 patients with biopsy-proven primary IgA nephropathy to examine the association between tonsillectomy and long-term renal survival, defined as the incidence of estimated glomerular filtration rates (eGFRs) of ≤30 ml/min/1.73 m(2) or end-stage renal disease (the composite of initiation of dialysis treatment or renal transplantation). The association of tonsillectomy with renal end-points was examined using the Kaplan-Meier method and Cox models.
RESULTS: One-hundred and sixty-six patients did not undergo tonsillectomy (Group I, follow-up 130 ± 101 months) and 98 patients underwent tonsillectomy (Group II, follow-up 170 ± 124 months). The mean renal survival time was significantly longer for both end-points between those patients who underwent tonsillectomy (Group II) versus patients without tonsillectomy (Group I) (p < 0.001 and p = 0.005). The mean renal survival time was significantly longer for both end-points between those patients who had macrohaematuric episodes versus patients who had no macrohaematuric episodes (p = 0.035 and p = 0.019). Tonsillectomy, baseline eGFR and 24-h proteinuria were independent risk factors for both renal end-points.
CONCLUSION: Tonsillectomy may delay the progression of IgA nephropathy mainly in IgA nephropathy patients with macrohaematuria. Prospective investigation of the protective role of tonsillectomy in Caucasian patients is needed.

Entities:  

Mesh:

Year:  2014        PMID: 25181956     DOI: 10.1007/s11255-014-0818-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  38 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.

Authors:  Isseki Maeda; Tomoshige Hayashi; Kyoko Kogawa Sato; Mikiko Okumoto Shibata; Masahiro Hamada; Masatsugu Kishida; Chizuko Kitabayashi; Takashi Morikawa; Noriyuki Okada; Michiaki Okumura; Masayo Konishi; Yoshio Konishi; Ginji Endo; Masahito Imanishi
Journal:  Nephrol Dial Transplant       Date:  2012-04-05       Impact factor: 5.992

3.  [Does tonsillectomy cause any change in long-term course of IgA nephropathy?].

Authors:  J Barta; T Kovács; A Fazekas; S Jeges; G Nagy; J Nagy
Journal:  Orv Hetil       Date:  1996-12-29       Impact factor: 0.540

4.  IgA nephropathy at two score and one.

Authors:  Rosanna Coppo; John Feehally; Richard J Glassock
Journal:  Kidney Int       Date:  2009-11-18       Impact factor: 10.612

Review 5.  Primary IgA nephropathy: new insights into pathogenesis.

Authors:  Jonathan Barratt; John Feehally
Journal:  Semin Nephrol       Date:  2011-07       Impact factor: 5.299

Review 6.  The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?

Authors:  Jürgen Floege
Journal:  Am J Kidney Dis       Date:  2011-08-26       Impact factor: 8.860

7.  Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis.

Authors:  Antonio Piccoli; Marta Codognotto; Maria-Grazia Tabbi; Enrico Favaro; Barbara Rossi
Journal:  Nephrol Dial Transplant       Date:  2010-03-02       Impact factor: 5.992

Review 8.  The pathogenesis of IgA nephropathy.

Authors:  Richard J Glassock
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

9.  A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report.

Authors:  Mariko Miyazaki; Osamu Hotta; Atsushi Komatsuda; Shigeru Nakai; Tatsuya Shoji; Chikao Yasunaga; Yoshio Taguma
Journal:  Contrib Nephrol       Date:  2007       Impact factor: 1.580

10.  The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes.

Authors:  A Rifai; K Fadden; S L Morrison; K R Chintalacharuvu
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  5 in total

Review 1.  The Treatment of IgA Nephropathy.

Authors:  Kar Neng Lai; Joseph C K Leung; Sydney C W Tang
Journal:  Kidney Dis (Basel)       Date:  2015-04-15

Review 2.  Long-term efficacy of tonsillectomy as a treatment in patients with IgA nephropathy: a meta-analysis.

Authors:  Jiayu Duan; Dongwei Liu; Guangcai Duan; Zhangzuo Liu
Journal:  Int Urol Nephrol       Date:  2016-10-08       Impact factor: 2.370

Review 3.  The Phenotypic Difference of IgA Nephropathy and its Race/Gender-dependent Molecular Mechanisms.

Authors:  Yusuke Suzuki; Renato C Monteiro; Rosanna Coppo; Hitoshi Suzuki
Journal:  Kidney360       Date:  2021-05-28

4.  Long-Term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A Nephropathy.

Authors:  Takahito Moriyama; Kazunori Karasawa; Yoei Miyabe; Kenichi Akiyama; Yuko Iwabuchi; Shota Ogura; Tomo Takabe; Naoko Sugiura; Momoko Seki; Norio Hanafusa; Keiko Uchida; Kosaku Nitta
Journal:  Kidney360       Date:  2020-09-02

Review 5.  Recent advances in the immunological understanding of association between tonsil and immunoglobulin A nephropathy as a tonsil-induced autoimmune/inflammatory syndrome.

Authors:  Yasuaki Harabuchi; Miki Takahara
Journal:  Immun Inflamm Dis       Date:  2019-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.